新城疫活疫苗对控制鸡大肠杆菌病的效果观察

为了研究鸡新城疫活疫苗紧急免疫控制鸡大肠杆菌病的效果,通过大肠杆菌人工感染30日龄蛋鸡,待出现病症后,紧急免疫新城疫La-sota弱毒苗(Ⅳ系)4羽份.免疫后5～17 d,通过血凝抑制试验测定血清新城疫抗体水平,试验组新城疫抗体水平逐步提高,对照组抗体略有下降,免疫后17 d两组抗体水平差异显著(P＜0.05);对照组...     

自拟中草药复方防治蛋雏鸡大肠杆菌病的研究

用自拟中草药复方对蛋雏鸡大肠杆菌病进行了病原菌体外药物敏感试验、中西药疗效对比试验及临床治疗和预防试验,并对自拟中草药复方进行了有效治疗剂量筛选试验和安全性试验。结果表明,自拟中草药复方对各生长阶段蛋雏鸡的安全性高,对大肠杆菌中度敏感;在饲料中有效治疗添加量为10g/kg,在治疗蛋雏鸡大肠杆菌病时获得了较好的治疗效果(有效率88.3%),但采取中西医合并治疗效果最好(有效率96.7%),与西药组和中药组相比差异显著(P<0.05);使用自拟中草药复方在临床上预防大肠杆菌病,发病率明显低于西药组,且二者差异显著(P<0.05);按8倍剂量使用仍较安全,未出现异常表现,剖检和组织切片检查也未发现异常变化。     

盐酸环丙沙星搽剂的研制及临床应用试验

环丙沙星是高效广谱抗菌新药,将其同透皮吸收促进剂（Ａｚｏｎｅ）按药剂学方法制成盐酸环丙沙星搽剂,稳定性良好．将药液涂搽于仔猪体表,用以防治哺乳仔猪大肠杆菌病,获得满意效果．     

氟苯尼考与三甲氧苄啶水溶性粉对试验性鸡大肠杆菌病的疗效研究

为测定氟苯尼考与三甲氧苄啶(TMP)水溶性粉配伍应用对鸡大肠杆菌病的疗效,将试验鸡分为健康对照组、感染对照组、氟苯尼考组和氟苯尼考与TMP配伍应用的高、中、低3个剂量组。经对比治疗,试验结果表明,氟苯尼考与TMP配伍应用对大肠杆菌病的疗效(极)显著优于其他对照组,其中以中、高剂量组最明显,但3个剂量组间无显著差异,最佳配伍比例为5∶1,药物浓度为50μg/mL,即每毫升药液中含氟苯尼考42μg,TMP为8μg。     

Inflammation-associated responses in piglets induced with post-weaning colibacillosis are influenced by dietary protein level

Forty piglets (average body weight = 5.32 kg) were used to investigate the effect of dietary crude protein (CP) content on immunological responses following a challenge with enterotoxigenic Escherichia coli (ETEC) K88. Pigs, housed 4 per pen, were randomly allotted to 2 diets: 1) a high, 225 g/kg CP diet (HCP) or 2) a low, 176 g/kg CP diet (LCP) supplemented with crystalline amino acids. Pigs were orally challenged with 6 mL of an ETEC K88 suspension containing 10¹⁰ cfu/mL on d 8 after weaning. Blood samples were collected from 10 pigs (1 pig/pen) on d 7 (at weaning), −24 h, 8 h, 72 h and 7 d after the challenge for determination of plasma urea N (PUN) and serum concentrations of tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) and haptoglobin (Hp). Tumor necrosis factor alpha, IL-1β and Hp were measured as indicators of inflammatory responses. The concentrations of serum TNF-α at 8 h, 72 h and 7 d after challenge were similar to the level observed at 24 h before challenge but higher (P < 0.05) than the weaning level. Pigs fed the LCP diet had lower (P = 0.032) concentrations of IL-1β (72 vs. 116 pg/mL) at 8 h post-challenge compared with those fed the HCP diet. Likewise, pigs fed the LCP diet tended to have lower (P = 0.088) concentration of Hp (9 vs. 25 mg/dL) compared with those fed the HCP diet at 8 h post-challenge. Compared with the weaning concentration, PUN concentration at 72 h after ETEC challenge was higher (P < 0.05) in pigs fed the HCP diet. The results indicate that the LCP diet supplemented with crystalline amino acids reduced inflammatory responses, as indicated by serum IL-1β, in piglets infected with ETEC K88.     

扎布耶盐山羊大肠杆菌分离鉴定及药敏试验

为掌握西藏自治区仲巴县帕江乡扎布耶盐山羊的发病情况,采集发病羊的粪便、血液、肝脏、脾脏、胸腔、腹腔和心包腔内蓄积的浆液性纤维性渗出物等进行病原菌分离鉴定及药敏试验。经病原菌分离鉴定,该地区扎布耶盐山羊羔羊感染的病原菌为大肠杆菌,检出率为97.14%(34/35);药敏试验结果表明,该研究分离得到的大肠杆菌对头孢唑林、青霉素、阿莫西林、头孢他啶、氟苯尼考、头孢拉啶6种药物高度敏感。该调查研究为仲巴县帕江乡扎布耶盐山羊大肠杆菌病的防治提供了诊断方法和用药方案。     

禽喘安对鸡霉形体与大肠杆菌合并感染的药效学研究

研究了中药散剂禽喘安对鸡霉形体与大肠杆菌合并感染的药效学。结果表明,禽喘安按０．７５％,０．５０％拌料连续５天,对鸡霉形体与大肠杆菌合并感染具有显著疗效,治愈率分别为９２．５０％,９０％;试验结束时,试验鸡只的抗体反应阳性率分别为２５％,５０％,气囊平均损伤记分分别为０．３３％,１．３３％。     

阿莫西林、舒巴坦联用对鸭实验性大肠杆菌病的疗效试验

用试管两倍稀释法测定了阿莫西林、阿莫西林与舒巴坦联合对大肠杆菌的体外抗菌活性,并观察阿莫西林与舒巴坦联合治疗耐阿莫西林大肠杆菌诱发的鸭大肠杆菌病的效果。结果表明:阿莫西林与舒巴坦联合对鸭大肠杆菌产酶菌株体外抗菌活性优于阿莫西林,表现为明显的体外协同作用。阿莫西林与舒巴坦联用治疗耐阿莫西林大肠杆菌诱发的鸭大肠杆菌病,按10mg/kg体重(以阿莫西林量计算)肌肉注射,阿莫西林与舒巴坦联用1∶1和2∶1的有效率、治愈率分别为92.5%、92.5%和85%、80%,均显著高于感染对照组、阿莫西林饮水组及阿莫西林肌肉注射组(P<0.01)。     

恩诺沙星对鸡大肠杆菌病及葡萄球菌病的药效研究

就畜禽专用氟喹诺酮类抗菌药恩诺沙星对鸡人工感染大肠杆菌病及葡萄球菌病的药效进行了研究。结果表明，恩诺沙星、氯霉素对大肠杆菌Ｏ７８的ＭＩＣ分别为０．０５、１．６０ｍｇ／Ｌ；恩诺沙星、红霉素对金黄色葡萄球菌Ｃ５６０５株的ＭＩＣ分别为０．２、３．２ｍｇ／Ｌ。人工发病试验中，恩诺沙星内服以５、１０、２０ｍｇ／ｋｇ剂量或肌注以２．５、５、１０ｍｇ／ｋｇ剂量，每天给药２次，连用３ｄ，对鸡大肠杆菌病及葡萄球菌病均有较好的疗效，其中对大肠杆菌病的疗效明显优于氯霉素     

禽大肠杆菌病疫苗研究进展

禽致病性大肠杆菌(APEC)是引起家禽多种肠外疾病如气囊炎、心包炎、肝周炎、蜂窝织炎及败血症的主要人畜共患病原菌.在过去的数十年间,试验了多种不同类型的疫苗用于本病的控制.鉴于APEC血清型较多且不同血清型之间缺乏交叉免疫保护,故生产上使用的APEC疫苗研究进展缓慢.作者对不同类型APEC疫苗进行了综述并提出未来的研究方向.